stockportfolio.pro
Krystal Biotech, Inc. Net Income 2016–2025
Krystal Biotech, Inc. (KRYS) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $204.83M | 52.6% | +129.7% |
| FY 2024 | $89.16M | 30.7% | +715.6% |
| FY 2023 | $10.93M | 21.6% | +107.8% |
| FY 2022 | $-139.97M | — | -101.2% |
| FY 2021 | $-69.57M | — | -116.3% |
| FY 2020 | $-32.17M | — | -68.5% |
| FY 2019 | $-19.09M | — | -75.3% |
| FY 2018 | $-10.89M | — | -37.5% |
| FY 2017 | $-7.92M | — | -588.7% |
| FY 2016 | $-1.15M | — | — |
Source: Krystal Biotech, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Krystal Biotech, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeKrystal Biotech, Inc. — frequently asked questions
What is Krystal Biotech, Inc.'s net income?
Krystal Biotech, Inc. (KRYS) reported net income of $204.83M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Krystal Biotech, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.